Cargando…
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
The pandemic COVID-19 has spread widely throughout the globe and has been responsible for millions of deaths worldwide. Recently, it has been identified that there is no specific and 100% effective treatment available to manage the infection especially for the severe cases. A significant amount of r...
Autores principales: | Chavda, Vivek P., Bezbaruah, Rajashri, Dolia, Sheetal, Shah, Nirav, Verma, Sachin, Savale, Shrinivas, Ray, Suma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886570/ https://www.ncbi.nlm.nih.gov/pubmed/36741339 http://dx.doi.org/10.1016/j.procbio.2023.01.018 |
Ejemplares similares
-
Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020) -
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
por: Ali, Shaukat, et al.
Publicado: (2021) -
Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
por: Basic-Jukic, Nikolina
Publicado: (2020) -
Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma
por: Vandeberg, Peter, et al.
Publicado: (2021) -
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
por: Mair-Jenkins, John, et al.
Publicado: (2015)